1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA GYPC CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA CD244 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA SERPINB1 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA GAB3 CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA GSDMD CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA APOBR CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA FHL3 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA MYOF CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA GBGT1 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA DDO CTRPv2 pan-cancer AAC -0.15 4e-05
Download CSV